209 related articles for article (PubMed ID: 21074265)
1. Protein composition of microparticles shed from human placenta during placental perfusion: Potential role in angiogenesis and fibrinolysis in preeclampsia.
Guller S; Tang Z; Ma YY; Di Santo S; Sager R; Schneider H
Placenta; 2011 Jan; 32(1):63-9. PubMed ID: 21074265
[TBL] [Abstract][Full Text] [Related]
2. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.
Gu Y; Lewis DF; Wang Y
J Clin Endocrinol Metab; 2008 Jan; 93(1):260-6. PubMed ID: 17956952
[TBL] [Abstract][Full Text] [Related]
3. Differential release of plasminogen activator inhibitors (PAIs) during dual perfusion of human placenta: implications in preeclampsia.
Guller S; Ma Y; Malek A; Di Santo S; Schneider H
Placenta; 2007 Apr; 28(4):278-85. PubMed ID: 16820203
[TBL] [Abstract][Full Text] [Related]
4. Placental release of distinct DNA-associated micro-particles into maternal circulation: reflective of gestation time and preeclampsia.
Orozco AF; Jorgez CJ; Ramos-Perez WD; Popek EJ; Yu X; Kozinetz CA; Bischoff FZ; Lewis DE
Placenta; 2009 Oct; 30(10):891-7. PubMed ID: 19692120
[TBL] [Abstract][Full Text] [Related]
5. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin.
Tannetta DS; Dragovic RA; Gardiner C; Redman CW; Sargent IL
PLoS One; 2013; 8(2):e56754. PubMed ID: 23437230
[TBL] [Abstract][Full Text] [Related]
7. Role of the syncytium in placenta-mediated complications of preeclampsia.
Guller S
Thromb Res; 2009 Sep; 124(4):389-92. PubMed ID: 19535132
[TBL] [Abstract][Full Text] [Related]
8. Association of microparticles and preeclampsia.
Marques FK; Campos FM; Sousa LP; Teixeira-Carvalho A; Dusse LM; Gomes KB
Mol Biol Rep; 2013 Jul; 40(7):4553-9. PubMed ID: 23645085
[TBL] [Abstract][Full Text] [Related]
9. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
Tong S; Kaitu'u-Lino TJ; Onda K; Beard S; Hastie R; Binder NK; Cluver C; Tuohey L; Whitehead C; Brownfoot F; De Silva M; Hannan NJ
Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507
[TBL] [Abstract][Full Text] [Related]
10. Microparticles and pregnancy complications.
Aharon A; Brenner B
Thromb Res; 2011 Feb; 127 Suppl 3():S67-71. PubMed ID: 21262446
[TBL] [Abstract][Full Text] [Related]
11. Placental expression of ceruloplasmin in pregnancies complicated by severe preeclampsia.
Guller S; Buhimschi CS; Ma YY; Huang ST; Yang L; Kuczynski E; Zambrano E; Lockwood CJ; Buhimschi IA
Lab Invest; 2008 Oct; 88(10):1057-67. PubMed ID: 18679377
[TBL] [Abstract][Full Text] [Related]
12. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
[TBL] [Abstract][Full Text] [Related]
13. Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia.
Masuyama H; Nakatsukasa H; Takamoto N; Hiramatsu Y
J Clin Endocrinol Metab; 2007 Jul; 92(7):2672-9. PubMed ID: 17426083
[TBL] [Abstract][Full Text] [Related]
14. Preeclampsia is associated with the presence of transcriptionally active placental fragments in the maternal lung.
Buurma AJ; Penning ME; Prins F; Schutte JM; Bruijn JA; Wilhelmus S; Rajakumar A; Bloemenkamp KW; Karumanchi SA; Baelde HJ
Hypertension; 2013 Sep; 62(3):608-13. PubMed ID: 23817495
[TBL] [Abstract][Full Text] [Related]
15. Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta.
Kaitu'u-Lino TJ; Brownfoot FC; Hastie R; Chand A; Cannon P; Deo M; Tuohey L; Whitehead C; Hannan NJ; Tong S
Hypertension; 2017 Nov; 70(5):1014-1024. PubMed ID: 28947613
[TBL] [Abstract][Full Text] [Related]
16. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM
Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761
[TBL] [Abstract][Full Text] [Related]
17. Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.
Xu B; Thornton C; Tooher J; Ogle R; Lim S; Makris A; Hennessy A
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):839-42. PubMed ID: 19215236
[TBL] [Abstract][Full Text] [Related]
18. Reduced placental protein 13 (PP13) in placental derived syncytiotrophoblast extracellular vesicles in preeclampsia - A novel tool to study the impaired cargo transmission of the placenta to the maternal organs.
Sammar M; Dragovic R; Meiri H; Vatish M; Sharabi-Nov A; Sargent I; Redman C; Tannetta D
Placenta; 2018 Jun; 66():17-25. PubMed ID: 29884298
[TBL] [Abstract][Full Text] [Related]
19. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
Holme AM; Roland MC; Henriksen T; Michelsen TM
Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
[TBL] [Abstract][Full Text] [Related]
20. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor.
Shibata E; Rajakumar A; Powers RW; Larkin RW; Gilmour C; Bodnar LM; Crombleholme WR; Ness RB; Roberts JM; Hubel CA
J Clin Endocrinol Metab; 2005 Aug; 90(8):4895-903. PubMed ID: 15886253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
